(Q67677208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

review article

1 reference

title

Role of interferons in the therapy of melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Role of Interferons in the Thearpy of Melanoma (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

2 November 2022

author name string

J. M. Kirkwood

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701805

2 November 2022

M. S. Ernstoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701805

2 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:S0022202X9091217Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

https://api.elsevier.com/content/article/PII:S0022202X9091217Y?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Journal of Investigative Dermatology

2 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

6 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

180S-184S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701805%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/1523-1747.ep12875497

16 September 2019

exact match

0 references

cites work

Risk for cutaneous melanoma in recent Connecticut birth cohorts

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Evaluation of human lymphoblastoid interferon in advanced malignant melanoma

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma

2 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Natural human interferon-beta in metastatic malignant melanoma. A phase II study

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanoma

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Phase-II study of recombinant alpha 2-interferon in advanced malignant melanoma

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN alpha, r-IFN gamma, and r-IFN alpha + cimetidine) in disseminated malignant melanoma

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Treatment of metastatic malignant melanoma with recombinant interferon alpha 2

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers.

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

The determination of an immunologically active dose of interferon-gamma in patients with melanoma

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay

2 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497

In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.

2 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12875497